期刊
MOLECULAR GENETICS & GENOMIC MEDICINE
卷 1, 期 3, 页码 162-173出版社
WILEY
DOI: 10.1002/mgg3.19
关键词
Duchenne muscular dystrophy; exon skipping; splice mutation; splice-switching oligomer
资金
- Muscular Dystrophy Association USA [173027]
- National Institutes of Health [2 ROI NS044146-05A1]
- National Health and Medical Research Council of Australia [634485]
- Duchenne Ireland
- Medical and Health Research Infrastructure Fund of Western Australia
- James and Matthew Foundation
- MRC [MR/K000608/1] Funding Source: UKRI
We describe two donor splice site mutations, affecting dystrophin exons 16 and 45 that led to Duchenne muscular dystrophy (DMD), through catastrophic inactivation of the mRNA. These gene lesions unexpectedly resulted in the retention of the downstream introns, thereby increasing the length of the dystrophin mRNA by 20.2 and 36 kb, respectively. Splice-switching antisense oligomers targeted to exon 16 excised this in-frame exon and the following intron from the patient dystrophin transcript very efficiently in vitro, thereby restoring the reading frame and allowing synthesis of near-normal levels of a putatively functional dystrophin isoform. In contrast, targeting splice-switching oligomers to exon 45 in patient cells promoted only modest levels of an out-of-frame dystrophin transcript after transfection at high oligomer concentrations, whereas dual targeting of exons 44 and 45 or 45 and 46 resulted in more efficient exon skipping, with concomitant removal of intron 45. The splice site mutations reported here appear highly amenable to antisense oligomer intervention. We suggest that other splice site mutations may need to be evaluated for oligomer interventions on a case-by-case basis.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据